Psychedelic NewsMay 27, 2021 A Second Psychedelics ETF Prepares To Trade… Here are the Top 10 Holdings
PressMay 27, 2021 Leading Psychedelic Wellness Platform, Delic, Completes Acquisition of Complex Biotech Discovery Ventures Ltd.
PressMay 26, 2021 MindMed and Liechti Lab in Basel Switzerland Publish First Pharmacogenetic Data on LSD to Help Guide Personalized Dosing
PressMay 25, 2021 PharmaTher Files for FDA Orphan Drug Designation for Ketamine to Treat Lou Gehrig’s Disease
PressMay 24, 2021 MindMed Announces Collaboration with Nextage Therapeutics’ Brain Targeting Liposome System
PressMay 21, 2021 The Chopra Foundation and MindMed to Partner on the Future of Psychedelic Medicines & Mental Wellbeing
PressMay 20, 2021 Awakn Life Sciences Inc. Enter into Binding Agreement for Reverse Takeover Transaction
PressMay 19, 2021 Silo Wellness Partners with Kaivalya Kollectiv to Include 5-MeO-DMT In Psychedelic Portfolio Offering
PressMay 19, 2021 MINDCURE Appoints Dr. John Brownstein, the Chief Innovation Officer at Boston Children’s Hospital, as Company Advisor
PressMay 18, 2021 HAVN Life to Acquire Clinical Stage IP for Development of LSD-Derived API for Cluster Headaches
PressMay 17, 2021 Revive Therapeutics Enters into Feasibility Agreement with LTS Lohmann to Develop Oral Psilocybin Thin Film Strip
PressMay 17, 2021 The World Boxing Council and Wesana Health Announce Joint Efforts to Research the Impact of Psychedelics on Traumatic Brain Injury
